180 related articles for article (PubMed ID: 38045268)
21. Receptor Activity-modifying Protein-directed G Protein Signaling Specificity for the Calcitonin Gene-related Peptide Family of Receptors.
Weston C; Winfield I; Harris M; Hodgson R; Shah A; Dowell SJ; Mobarec JC; Woodlock DA; Reynolds CA; Poyner DR; Watkins HA; Ladds G
J Biol Chem; 2016 Oct; 291(42):21925-21944. PubMed ID: 27566546
[TBL] [Abstract][Full Text] [Related]
22. Functions of third extracellular loop and helix 8 of Family B GPCRs complexed with RAMPs and characteristics of their receptor trafficking.
Kuwasako K; Hay DL; Nagata S; Murakami M; Kitamura K; Kato J
Curr Protein Pept Sci; 2013 Aug; 14(5):416-28. PubMed ID: 23745705
[TBL] [Abstract][Full Text] [Related]
23. RAMPs: 5 years on, where to now?
Morfis M; Christopoulos A; Sexton PM
Trends Pharmacol Sci; 2003 Nov; 24(11):596-601. PubMed ID: 14607083
[TBL] [Abstract][Full Text] [Related]
24. Determining the Effects of Differential Expression of GRKs and β-arrestins on CLR-RAMP Agonist Bias.
Pearce A; Redfern-Nichols T; Harris M; Poyner DR; Wigglesworth M; Ladds G
Front Physiol; 2022; 13():840763. PubMed ID: 35422711
[TBL] [Abstract][Full Text] [Related]
25. Systematic protein-protein interaction mapping for clinically relevant human GPCRs.
Sokolina K; Kittanakom S; Snider J; Kotlyar M; Maurice P; Gandía J; Benleulmi-Chaachoua A; Tadagaki K; Oishi A; Wong V; Malty RH; Deineko V; Aoki H; Amin S; Yao Z; Morató X; Otasek D; Kobayashi H; Menendez J; Auerbach D; Angers S; Pržulj N; Bouvier M; Babu M; Ciruela F; Jockers R; Jurisica I; Stagljar I
Mol Syst Biol; 2017 Mar; 13(3):918. PubMed ID: 28298427
[TBL] [Abstract][Full Text] [Related]
26. The role of GPCR dimerisation/oligomerisation in receptor signalling.
Milligan G; Canals M; Pediani JD; Ellis J; Lopez-Gimenez JF
Ernst Schering Found Symp Proc; 2006; (2):145-61. PubMed ID: 17703581
[TBL] [Abstract][Full Text] [Related]
27. Structural insights into RAMP modification of secretin family G protein-coupled receptors: implications for drug development.
Archbold JK; Flanagan JU; Watkins HA; Gingell JJ; Hay DL
Trends Pharmacol Sci; 2011 Oct; 32(10):591-600. PubMed ID: 21722971
[TBL] [Abstract][Full Text] [Related]
28. Regulation of GPCR activity, trafficking and localization by GPCR-interacting proteins.
Magalhaes AC; Dunn H; Ferguson SS
Br J Pharmacol; 2012 Mar; 165(6):1717-1736. PubMed ID: 21699508
[TBL] [Abstract][Full Text] [Related]
29. Multiplexed selectivity screening of anti-GPCR antibodies.
Dahl L; Kotliar IB; Bendes A; Dodig-Crnković T; Fromm S; Elofsson A; Uhlén M; Sakmar TP; Schwenk JM
Sci Adv; 2023 May; 9(18):eadf9297. PubMed ID: 37134173
[TBL] [Abstract][Full Text] [Related]
30. Regulation of GPCR trafficking by RAMPs.
Bomberger JM; Parameswaran N; Spielman WS
Adv Exp Med Biol; 2012; 744():25-37. PubMed ID: 22434105
[TBL] [Abstract][Full Text] [Related]
31. The effects of RAMPs upon cell signalling.
Routledge SJ; Ladds G; Poyner DR
Mol Cell Endocrinol; 2017 Jul; 449():12-20. PubMed ID: 28390954
[TBL] [Abstract][Full Text] [Related]
32. Novel receptor partners and function of receptor activity-modifying proteins.
Christopoulos A; Christopoulos G; Morfis M; Udawela M; Laburthe M; Couvineau A; Kuwasako K; Tilakaratne N; Sexton PM
J Biol Chem; 2003 Jan; 278(5):3293-7. PubMed ID: 12446722
[TBL] [Abstract][Full Text] [Related]
33. Complexing receptor pharmacology: modulation of family B G protein-coupled receptor function by RAMPs.
Sexton PM; Morfis M; Tilakaratne N; Hay DL; Udawela M; Christopoulos G; Christopoulos A
Ann N Y Acad Sci; 2006 Jul; 1070():90-104. PubMed ID: 16888151
[TBL] [Abstract][Full Text] [Related]
34. RAMP3 determines rapid recycling of atypical chemokine receptor-3 for guided angiogenesis.
Mackie DI; Nielsen NR; Harris M; Singh S; Davis RB; Dy D; Ladds G; Caron KM
Proc Natl Acad Sci U S A; 2019 Nov; 116(48):24093-24099. PubMed ID: 31712427
[TBL] [Abstract][Full Text] [Related]
35. Evidence for Conservation of the Calcitonin Superfamily and Activity-regulating Mechanisms in the Basal Chordate Branchiostoma floridae: INSIGHTS INTO THE MOLECULAR AND FUNCTIONAL EVOLUTION IN CHORDATES.
Sekiguchi T; Kuwasako K; Ogasawara M; Takahashi H; Matsubara S; Osugi T; Muramatsu I; Sasayama Y; Suzuki N; Satake H
J Biol Chem; 2016 Jan; 291(5):2345-56. PubMed ID: 26644465
[TBL] [Abstract][Full Text] [Related]
36. The receptor activity modifying protein family of G protein coupled receptor accessory proteins.
Udawela M; Hay DL; Sexton PM
Semin Cell Dev Biol; 2004 Jun; 15(3):299-308. PubMed ID: 15125893
[TBL] [Abstract][Full Text] [Related]
37. Genetically encoded intrabody sensors report the interaction and trafficking of β-arrestin 1 upon activation of G-protein-coupled receptors.
Baidya M; Kumari P; Dwivedi-Agnihotri H; Pandey S; Sokrat B; Sposini S; Chaturvedi M; Srivastava A; Roy D; Hanyaloglu AC; Bouvier M; Shukla AK
J Biol Chem; 2020 Jul; 295(30):10153-10167. PubMed ID: 32439801
[TBL] [Abstract][Full Text] [Related]
38. Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product.
Christopoulos G; Perry KJ; Morfis M; Tilakaratne N; Gao Y; Fraser NJ; Main MJ; Foord SM; Sexton PM
Mol Pharmacol; 1999 Jul; 56(1):235-42. PubMed ID: 10385705
[TBL] [Abstract][Full Text] [Related]
39. Agonist-selective recruitment of engineered protein probes and of GRK2 by opioid receptors in living cells.
Stoeber M; Jullié D; Li J; Chakraborty S; Majumdar S; Lambert NA; Manglik A; von Zastrow M
Elife; 2020 Feb; 9():. PubMed ID: 32096468
[TBL] [Abstract][Full Text] [Related]
40. Receptor activity-modifying protein-dependent impairment of calcitonin receptor splice variant Δ(1-47)hCT((a)) function.
Qi T; Dong M; Watkins HA; Wootten D; Miller LJ; Hay DL
Br J Pharmacol; 2013 Feb; 168(3):644-57. PubMed ID: 22946511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
